Amyris, Inc., (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it closed the acquisitions of OLIKA, Inc. (OLIKA), an award-winning clean consumer brand, and MG Empower Ltd., a leading global influencer marketing agency on August 11.
OLIKA is transforming the hygiene category through a dedication to transparency, combining the safest, most effective ingredients and packaged in beautiful, nature-inspired design. Recently, the award-winning on-the-go clean wellness brand launched in the gift and boutique channel and added Sprouts Farmers Market, the leading natural grocery channel to its lineup. The OLIKA Hydrating Hand Sanitizer Collections can be purchased at OLIKALife.com, Amazon, Albertsons/Safeway/Jewel Stores, Anthropologie, Bloomingdales, Lou Lou Boutique, Kroger, Hy-Vee, Macy’s Backstage, Earth Fare, Raley’s, Thrive Market, and Wegmans.
OLIKA was co-founded by Jessica Postiglione, Nicolas Perkin, and Thorne Perkin in 2015 with Ms. Postiglione acting as CEO of the company developing and bringing to market OLIKA’s design-forward hand sanitizer products Birdie and Minnie. She was responsible for the growth of the business’ DTC sales, Amazon presence, and product launches in retailers nationwide until 2019. In recent years, OLIKA was led by Alastair Dorward as CEO. Mr. Dorward and his team have joined the Amyris family of consumer brands.
MG Empower, founded by Maira Genovese in 2017, is the influencer marketing and digital innovation partner to some of the world’s most influential brands, including Amyris, Inc., Bumble, Chopard, StarzPlay, Deliveroo, and TikTok Bytedance. Based in London, England, and operating across five continents, the agency has built a powerful proprietary influencer CRM and a network of over 5 million influencers, producing innovative, award-winning influencer marketing campaigns that have reached over a billion people. Amyris’ acquisition of MG Empower represents its continued investment in the future of marketing innovation by establishing a unique operating model that places digital technology and influencer marketing at the core of its consumer growth strategy. Ms. Genovese and her team have joined Amyris to support Amyris’ family of consumer brands as well as external clients.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
“After working closely with Maira and her team on developing leading social marketing campaigns it’s a great pleasure to have them as part of the Amyris family,” commented John Melo, President and Chief Executive Officer of Amyris. “I’m also very pleased to have the brand-building expertise and proven track record of Alastair and the OLIKA team join our family of brands and provide us greater bandwidth for growth. Both of these acquisitions are generating new revenue for Amyris and represent continued execution and further vertical integration of our leadership in selling directly to the consumer.”
Forward-Looking Statements
This release contains forward-looking statements, and any statements other than statements of historical fact could be deemed to be forward-looking statements. These forward-looking statements include, among other things, statements regarding Amyris’ expectations that the OLIKA team will provide greater bandwidth for Amyris’ growth and that the acquisitions will generate new revenue for Amyris. These statements are based on management’s current expectations and actual results and future events may differ materially due to risks and uncertainties, including risks related to any delays or failures in the successful launch of a clean skincare brand; potential delays or failures in development, production, regulatory approval and commercialization of products, risks related to Amyris’ reliance on third parties; Amyris’ liquidity and ability to fund operating and capital expenses; and other risks detailed from time to time in filings Amyris makes with the Securities and Exchange Commission, including Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. Amyris disclaims any obligation to update the information contained in these forward-looking statements, whether as a result of new information, future events, or otherwise.
Source: Biospace
